REFERENCES
- Berrettini M, Buoncristiani U, Parise P, Ballatori E, Nenci GG. Polyacrilonytrile versus Cuprophan membranes for hemodialysis: evaluation of efficiency and biocompatibility by platelet aggregation studies. Int J Artif Organs 1981; 4: 218–22.
- Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178–95.
- Deykin D. Uremic bleeding. Kidney Int 1983; 24: 698–705.
- Handeland GF, Abildgaard U, Aasen AO. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated methods. Scand J Haematol 1983; 31: 427–36.
- Knudsen F, Nielsen AH, Stoffersen E, Kornerup HJ, Dyerberg J. Effect of inhibition of prostaglandin synthesis on platelet count, platelet aggregates and arterial oxygen tension during hemodialysis. Blood Purif 1983; 1: 242–6.
- Kristensen SD, Knudsen F, Nielsen AH, Ring T. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis. Clin Nephrol 1984; 21: 230–4.
- Levin RD, Kwaan HC, Ivanovich P. Changes in platelet function during hemodialysis. J Lab Clin Med 1978; 92: 779–86.
- Lindsay RM, Moorthy AV, Koens F, Linton AL. Platelet function in dialyzed and non-dialyzed patients with chronic renal failure. Clin Nephrol 1975; 4: 52–7.
- Lindsay RM, Freisen M, Koens F, Linton AL, Oreopoulos D, De Veber G. Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 1976; 6: 335–9.
- Lindsay RM, Freisen M, Aronstam A, Andrus F, Clark WF, Linton AL. Improvement of platelet function by increased frequency of hemodialysis. Clin Nephrol 1978; 10: 67–70.
- Mancini G, Carbonara AD, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochem 1965; 2: 235–254.
- Silberbauer KF, Wolf A, Stummvoll HK, Sinzinger H, Ring F, Pingera WF. Zirkulierende Thrombozytenaggregate während Hämodialyse. Klin Wochenschr 1979; 57: 1137–8.
- Sreeharan N, Crow MJ, Salter MCP, Donaldson DR, Rajah SM, Davidson AM. Membrane effect on platelet function during hemodialysis: a comparison of cuprophane and polycarbonate. Artif Organs 1982; 6: 324–7.
- Swartz RD, Port FK. Preventing hemorrhage in highrisk hemodialysis: Regional versus low-dose heparin. Kidney Int 1979; 16: 513–8.
- Thomson C, Forbes CD, Prentice CRM. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med 1973; 45: 485–94.
- Turney JH, Fewell MR, Williams LC, Parsons V, Weston MJ. Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet 1980; ii: 219–22.
- Turney JH, Dodd NJ, Williams LC, Weston MJ. Prostacyclin prevents endothelial and platelet damage during dialysis. Proc Eur Dial Transplant Ass 1981; 18: 111–6.
- Turney JH, Fewell M, Williams LC, Dodd N, Weston MJ. Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin. Clin Nephrol 1982; 17: 31–35.
- Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; ii: 924–6.
- Ylikorkala O, Huttunen K, Järvi J, Viinikka L. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. Clin Nephrol 1982; 18: 83–7.